Commercializing Precision Health: Challenges and Potential

LifeNome is thrilled to sponsor the 2024 Precision Health Summit, an event that promises to reshape the landscape of personalized medicine. Join us for this transformative two-day event where thought leaders and innovators will dive deep into the future of health, genomics, and data-driven solutions.

We are proud to announce Aquil Harjivan , R&D Head of Frontend Innovation at Bayer, as a key speaker. Aquil is a scientist by training and has extensive experience in the FMCG (Fast-Moving Consumer Goods) and consumer healthcare sectors, having worked across P&G, Unilever, GSK, and now Bayer. His career has been centered on innovation, product development, and leveraging science and technology to solve complex health challenges.

Since joining Bayer in 2021, Aquil has led the company’s digital health strategy and now heads frontend innovation. In this role, he focuses on creating new products and services that push the boundaries of healthcare, expanding the scope of Bayer’s impact across the patient journey. His work addresses the intersection of technology, human behavior, and healthcare, emphasizing how advancements in digital health can transform personalized care.

What Aquil Will Talk About

On October 9, from 11:30 AM to 12:00 PM ET, Aquil will deliver a presentation titled “Commercializing Precision Health: Challenges and Potentials.” In this session, he will discuss the significant challenges and exciting opportunities involved in bringing precision health innovations to market. Aquil will explore topics such as:

- Regulatory hurdles: Understanding the complex approval processes that precision health technologies face.

- Consumer adoption: How to make precision health accessible and appealing to the broader public.

- Technological advancements: Leveraging AI, genomics, and data-driven solutions to create innovative healthcare products.

- Scaling innovations: The steps required to transition from lab-based discoveries to widespread commercial success.

Aquil will also share real-world insights from Bayer's journey in digital health and their efforts to drive innovation across the healthcare spectrum.

About Bayer

Bayer is one of the world’s leading pharmaceutical and life sciences companies, with a mission to “Science for a Better Life. The company is at the forefront of research and innovation in healthcare, particularly in the fields of pharmaceuticals, consumer health, and crop science. Bayer’s work in digital health,

Bayer’s efforts in consumer healthcare and precision health have been transformative, focusing on preventative health solutions and enhancing patient well-being through personalized approaches. By understanding individual health data and behaviors, Bayer is designing products that offer more tailored and effective health interventions. This focus on precision medicine aligns with the core themes of the 2024 Precision Health Summit, making Aquil’s session a must-attend for anyone interested in the future of healthcare innovation.

Event Details:

- Dates: October 9-10, 2024

- Day 1: In-person at One World Trade Center, New York City

- Day 2: Online **Virtual pass holders can access live streams of all sessions)

Alongside Aquil Harjivan, the summit will feature over 50 distinguished experts, including leaders from organizations such as LifeNome, MIT, Johnson & Johnson, Bayer, and Chase Bank. These experts will provide insights into precision nutrition, genomics, preventive health, and innovative data-driven health solutions.

This summit offers a unique opportunity to engage with top industry experts and explore the latest advancements in personalized medicine. Register today to secure your spot Precision Health Summit 2024].

We look forward to seeing you at the summit!

#PrecisionHealth #Pharma #ConsumerHealth #health trends